Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 358 | 358 | 354 | 442 | 314 |
| Gross Profit | 358 | 358 | 354 | 442 | 314 |
| Operating Expenses | 10,898 | 13,158 | 8,100 | 6,661 | 5,613 |
| Operating Income | -10,540 | -12,800 | -7,746 | -6,219 | -5,299 |
| Interest Expense | 0 | 0 | 0 | 0 | -1 |
| Other Income | 5 | 5 | 5 | 8 | 0 |
| Pre-tax Income | -10,535 | -12,794 | -7,741 | -6,211 | -5,299 |
| Income Tax | N/A | N/A | 3 | 0 | N/A |
| Net Income Continuous | -10,535 | -12,794 | -7,745 | -6,211 | -5,299 |
| Net Income | $-10,535 | $-12,794 | $-7,745 | $-6,211 | $-5,299 |
| EPS Basic Total Ops | -1.50 | -2.10 | -1.20 | -9.01 | -2.10 |
| EPS Basic Continuous Ops | -1.56 | -1.99 | -1.22 | -0.98 | -1.96 |
| EPS Diluted Total Ops | -1.50 | -2.10 | -1.20 | -9.01 | -2.10 |
| EPS Diluted Continuous Ops | -1.56 | -1.99 | -1.22 | -0.98 | -1.96 |
| EBITDA(a) | $-10,497 | $-12,763 | $-7,712 | $-6,179 | $-5,273 |